DYRONIB 50MG

DYRONIB 50MG Specification

Pacakaging (Quantity Per Box)
60

Dosage Form
AS PER DOCTORS RECOMENDATION

Indication
types of chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL),

Salt Composition
AS PER DOCTORS RECOMENDATION

Origin of Medicine
india

Drug Type
Specific Drug

Ingredients
Dasatinib 50MG

Physical Form
Tablets

Function
Anti-Cancer

Recommended For
ANTI-CANCER

Dosage
AS PER DOCTORS RECOMENDATION

Dosage Guidelines
AS PER DOCTORS RECOMENDATION

Suitable For
Adults

Quantity
100 Boxes

Storage Instructions
Cool and Dry place

DYRONIB 50MG Trade Information

Minimum Order Quantity
1 Bottle

Payment Terms
Paypal, Cash on Delivery (COD), Cash in Advance (CID), Western Union

Supply Ability
10 Bottles Per Day

Delivery Time
3 Days

Sample Policy
Contact us for information regarding our sample policy

Main Export Market(s)
Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa

Main Domestic Market
All India

About DYRONIB 50MG

Dasatinib, sold under the brand name DYRONIB, is a targeted therapy medication used to treat certain types of chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL), specifically those that are Philadelphia chromosome-positive, and is taken orally.

Tell us about your requirement